TherapeuticsMD Statistics
Share Statistics
TherapeuticsMD has 11.57M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 11.57M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 30.6% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 454 |
| FTD / Avg. Volume | 0.89% |
Short Selling Information
The latest short interest is 90.6K, so 0.78% of the outstanding
shares have been sold short.
| Short Interest | 90.6K |
| Short % of Shares Out | 0.78% |
| Short % of Float | 1.07% |
| Short Ratio (days to cover) | 1.71 |
Valuation Ratios
The PE ratio is -4.55 and the forward
PE ratio is 6.41.
TherapeuticsMD's PEG ratio is
0.07.
| PE Ratio | -4.55 |
| Forward PE | 6.41 |
| PS Ratio | 5.63 |
| Forward PS | 1.3 |
| PB Ratio | 0.36 |
| P/FCF Ratio | 8.48 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for TherapeuticsMD.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.37,
with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.37 |
| Quick Ratio | 2.37 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | -3.91 |
| Debt / FCF | 6.13 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $1,761,000 |
| Profits Per Employee | $-2,181,000 |
| Employee Count | 1 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -31K |
| Effective Tax Rate | 1.32% |
Stock Price Statistics
The stock price has increased by -50.23% in the
last 52 weeks. The beta is 0.64, so TherapeuticsMD's
price volatility has been higher than the market average.
| Beta | 0.64 |
| 52-Week Price Change | -50.23% |
| 50-Day Moving Average | 1.2 |
| 200-Day Moving Average | 1.3 |
| Relative Strength Index (RSI) | 31.25 |
| Average Volume (20 Days) | 51,282 |
Income Statement
In the last 12 months, TherapeuticsMD had revenue of 1.76M
and earned -2.18M
in profits. Earnings per share was -0.19.
| Revenue | 1.76M |
| Gross Profit | 1.25M |
| Operating Income | -4.76M |
| Net Income | -2.18M |
| EBITDA | -1.83M |
| EBIT | -3.49M |
| Earnings Per Share (EPS) | -0.19 |
Full Income StatementBalance Sheet
The company has 5.06M in cash and 7.17M in
debt, giving a net cash position of -2.12M.
| Cash & Cash Equivalents | 5.06M |
| Total Debt | 7.17M |
| Net Cash | -2.12M |
| Retained Earnings | -951.82M |
| Total Assets | 38.24M |
| Working Capital | 7.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.17M
and capital expenditures 0, giving a free cash flow of 1.17M.
| Operating Cash Flow | 1.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | 1.17M |
| FCF Per Share | 0.1 |
Full Cash Flow StatementMargins
Gross margin is 71.1%, with operating and profit margins of -270.3% and -123.85%.
| Gross Margin | 71.1% |
| Operating Margin | -270.3% |
| Pretax Margin | -133.05% |
| Profit Margin | -123.85% |
| EBITDA Margin | -104.15% |
| EBIT Margin | -270.3% |
| FCF Margin | 66.44% |
